世界のH1N1ワクチン市場予測2021年-2026年

◆英語タイトル:H1N1 Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026
◆商品コード:IMA21AP109
◆発行会社(リサーチ会社):IMARC
◆発行日:2021年4月
◆ページ数:109
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD2,299 ⇒換算¥252,890見積依頼/購入/質問フォーム
Five UserUSD3,399 ⇒換算¥373,890見積依頼/購入/質問フォーム
EnterprisewideUSD4,499 ⇒換算¥494,890見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はIMARC社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
IMARC社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、世界のH1N1ワクチン市場を調査・分析し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、ワクチン別分析、種類別分析、地域別分析、主要商標分析、SWOT分析、バリューチェーン分析、ファイブフォース分析、価格分析、産業開発、競争状況などを掲載しています。
【レポートの概要】

The global H1N1 vaccines market reached a value of US$ 1.8 Billion in 2020. The H1N1 virus is an infectious disease characterized by a persistent cough, high fever, red-watery eyes, body aches and headache. The illness is known to have a detrimental effect on the existing chronic ailments, such as Pneumonia, Chronic Obstructive Pulmonary Disease (COPD) and Bronchitis, and can be fatal in severe cases. H1N1 vaccines are a preventive measure administered through intradermal and intranasal procedures to provide active immunization against the virus.
Increasing incidences of epidemic H1N1 infection and declining immunity of the general population are among the key factors driving the market growth. With increasing age, the risk of developing respiratory tract diseases and immunodeficiency disorders also escalates, thereby increasing the risk of acquiring the H1N1 flu infection. However, extensive research and development in the field of immunology and vaccine technologies coupled with extensive support from global health organizations are expected to promote the distribution of quality vaccines. Moreover, a number of developed countries such as Australia, the United Kingdom, and the United States have also included H1N1 vaccinations under their National Immunization Program (NIP) that has increased the demand for these vaccines. Additionally, technological advancements coupled with a rising awareness amongst patients about preventive methods has also led to a heightened demand for H1N1 vaccines. Looking forward, IMARC Group expects the global H1N1 vaccines market to exhibit moderate growth during the next five years.

IMARC Group’s latest report provides a deep insight into the global H1N1 vaccines market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the global H1N1 vaccines market in any manner.

Report Coverage:

Historical, Current and Future Market Trends

Breakup by Vaccine Type
Intramuscular
Intranasal
Intradermal

Breakup by Market Type:
Public
Private

Analysis of Key Brands:
Agripal
Fiuarix
Influgen
Influvac
Nasovac
Vaxigrip
Others

Breakup by Region:
North America
Europe
Asia Pacific
Middle East and Africa
Latin America

Competitive Landscape:

The report has also analysed the competitive landscape of the market along with the profiles of the key players.

Key Questions Answered in This Report:

How has the global H1N1 vaccines market performed so far and how will it perform in the coming years?
What are the key regional markets?
What has been the impact of COVID-19 on the global H1N1 vaccines industry?
What are the popular vaccines type?
What are the major market types?
What are the various stages in the value chain of the global H1N1 vaccines industry?
What are the key driving factors and challenges in the global H1N1 vaccines market?
What is the structure of the global H1N1 vaccines industry and who are the key players?
What is the degree of competition in the industry?
What are the profit margins in the industry?

【レポートの目次】

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global H1N1 Vaccines Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Breakup by Vaccines Type
5.5 Breakup by Market Type
5.6 Analysis of Key Brands
5.7 Breakup by Region
5.8 Market Forecast
6 Market Breakup by Vaccines Type
6.1 Intramuscular
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Intranasal
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Intradermal
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Type
7.1 Public
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Private
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Region
8.1 North America
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Europe
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Asia Pacific
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Middle East and Africa
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Latin America
8.5.1 Market Trends
8.5.2 Market Forecast
9 Analysis of Key Brand
9.1 Agripal
9.2 Fiuarix
9.3 Influgen
9.4 Influvac
9.5 Nasovac
9.6 Vaxigrip
9.7 Others
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
13.1 Price Indicators
13.2 Price Structure
13.3 Margin Analysis
14 Industry Developments
14.1 Pipeline and New Product Launches
14.2 Mergers & Acquisitions and Partnerships
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players

Figure 1: Global: H1N1 Vaccines Market: Major Drivers and Challenges
Figure 2: Global: H1N1 Vaccines Market: Sales Value (in Billion US$), 2015 - 2020
Figure 3: Global: H1N1 Vaccines Market: Breakup by Vaccines Type (in %), 2020
Figure 4: Global: H1N1 Vaccines Market: Breakup by Type (in %), 2020
Figure 5: Global: H1N1 Vaccines Market: Breakup by Region (in %), 2020
Figure 6: Global: H1N1 Vaccines Industry: SWOT Analysis
Figure 7: Global: H1N1 Vaccines Industry: Value Chain Analysis
Figure 8: Global: H1N1 Vaccines Industry: Porter’s Five Forces Analysis
Figure 9: Global: H1N1 Vaccines Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 10: Global: H1N1 Vaccines (Intramuscular) Market: Sales Value (in Million US$), 2015 & 2020
Figure 11: Global: H1N1 Vaccines (Intramuscular) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 12: Global: H1N1 Vaccines (Intranasal) Market: Sales Value (in Million US$), 2015 & 2020
Figure 13: Global: H1N1 Vaccines (Intranasal) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 14: Global: H1N1 Vaccines (Intradermal) Market: Sales Value (in Million US$), 2015 & 2020
Figure 15: Global: H1 N1 Vaccines (Intradermal) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 16: Global: H1N1 Vaccines (Public) Market: Sales Value (in Million US$), 2015 & 2020
Figure 17: Global: H1N1 Vaccines (Public) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 18: Global: H1N1 Vaccines (Private) Market: Sales Value (in Million US$), 2015 & 2020
Figure 19: Global: H1N1 Vaccines (Private) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 20: North America: H1N1 Vaccines Market: Sales Value (in Million US$), 2015 & 2020
Figure 21: North America: H1N1 Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 22: Europe: H1N1 Vaccines Market: Sales Value (in Million US$), 2015 & 2020
Figure 23: Europe: H1N1 Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 24: Asia Pacific: H1N1 Vaccines Market: Sales Value (in Million US$), 2015 & 2020
Figure 25: Asia Pacific: H1N1 Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 26: Middle East and Africa: H1N1 Vaccines Market: Sales Value (in Million US$), 2015 & 2020
Figure 27: Middle East and Africa: H1N1 Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 28: Latin America: H1N1 Vaccines Market: Sales Value (in Million US$), 2015 & 2020
Figure 29: Latin America: H1N1 Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026

Table 1: Global: H1N1 Vaccines Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: H1N1 Vaccines Market Forecast: Breakup by Vaccines Type (in Million US$), 2021-2026
Table 3: Global: H1N1 Vaccines Market Forecast: Breakup by Type (in Million US$), 2021-2026
Table 4: Global: H1N1 Vaccines Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 5: Global: H1N1 Vaccines Market Structure
Table 6: Global: H1N1 Vaccines Market: Key Players

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界のH1N1ワクチン市場予測2021年-2026年]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆